4 November 2025
Latham & Watkins Advises Manifold Bio on US$2 Billion Strategic Collaboration With Roche to Develop Multiple Next-Generation Brain Shuttles for Neurological Diseases
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Kate Hillier Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Arun Mohan | Latham & Watkins LLP | Associate | corporate | Not stated |
| John Pierce | Latham & Watkins LLP | Partner | arbitration | New York |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Derek Gumm | Latham & Watkins LLP | Associate | tax | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 2bn (US$2 Billion)
- What the figure measures
- Total transaction value
- Client
- Manifold BioOther
- Counterparties
- Roche (Other)